Contact
ou

Monsieur FAVRESSE Julien


Pharmacien biologiste

Laboratoire de Biologie Clinique


Contact :

Secrétariat : 081 20 91 54


FORMATION
  • 2014-2019 : Master complémentaire en biologie clinique – UCL
  • 2009-2014 : Master en Sciences Pharmaceutique – UCL

Publications
  1. Favresse J, Gruson D. Natriuretic peptides: degradation, circulating forms, dosages and new therapeutic approaches.. Ann Biol Clin (Paris) 2017, 75:259-267.
  2. Favresse J, Paridaens H, Pirson N, Maiter D, Gruson D. Massive interference in free T4 and free T3 assays misleading clinical judgment. Clin Chem Lab Med 2017; 55: e84-e86.
  3. Favresse J, Bastin P, Fillée C, Luyckx F, Maiter D, Gruson D. Tracking Macroprolactin: Use of an optimized polyethylene glycol precipitation method more compatible with the requirements and processes of automated core laboratories. J Appl Lab Med 2017; 1:661-667.
  4. Favresse J, Despas N, Gruson D, Vincent MF, Fillée C. Pre-analytics of ammonia: Crioplast® devices as an alternative to icy water. Clin Chim Acta. 2017, 472:102-103.
  5. Bastin P, Favresse J, Streel C, Maisin D, Fillée C, Gruson D. Assessment of in vitro stability: a call for harmonization across studies. Clin Chem Lab Med. 2018,56(5):e121-e124.
  6. Favresse J, Despas N, Boland L, Gruson D, Laterre PF, Nassogne MC, Vincent MF, Fillée C. Preanalytics of ammonia: stability, transport and temperature of centrifugation. Clin Chem Lab Med. 2018,23;56:e65-e68.
  7. Favresse J, van Dievoet MA, De Wolf H, Rodriguez-Villalobos H, Defour JP. Characterization of Candida spp. interference on the Sysmex XN-1000 body fluid mode. Int J Lab Hematol. 2018,40(2):e28-e32.
  8. Favresse J, Lardinois B, Chatelain B, Mullier F, Jacqmin H. A reminder of the place of morphology and the H-score in the diagnosis of hemophagocytic lymphohistiocytosis (HLH). Clin Case Report 2018,6(3):527-528.
  9. Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, Gruson D. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med 2018,27;56(7):e160-e163.
  10. Favresse J, Lardinois B, Chatelain B, Jacqmin H, Mullier F. Evaluation of the fully automated HemosIL® Acustar ADAMTS13 Activity assay. Thromb Haemost 2018,118(5):942-944.
  11. Favresse J, Lardinois B, Sabor L, Devalet B, Vandepapelier J, Braibant M, Lessire S, Chatelain B, Jacqmin H, Douxfils J, Mullier F. Evaluation of the DOAC-Stop® procedure to overcome the effect of DOACs on several thrombophilia screening tests. TH Open 2018; 02(02): e202-e209.
  12. Favresse J, Burlacu MA, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocrine Reviews, 2018, doi: 10.1210/er.2018-00119
  13. Favresse J, Lippi G, Ten Cate H, Mullier F. D-dimers: preanalytics, analytics, postanalytics, and clinical interests. Critical Reviews in Clinical Laboratory Sciences 2018, under review.
  14. Dincq AS, Lessire S, Pirard G, Siriez R, Guldenpfennig M, Baudar J, Favresse J, Douxfils J, Mullier F. Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method. Int J Lab Hematol. 2018, Epub ahead of print.